Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens. (Q48481526)

11 February 2018

title

Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens. (English)

1 reference

11 February 2018

0 references

0 references

1 reference

D L Willins

1

1 reference

11 February 2018

H Y Meltzer

series ordinal

2

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

11 February 2018

published in

Brain Research

1 reference

11 February 2018

volume

781

1 reference

11 February 2018

issue

1-2

1 reference

11 February 2018

page(s)

291-299

1 reference

11 February 2018

Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

MK-212: A serotonin-like agonist in the CNS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

In vivo evidence that 5-hydroxytryptamine (5-HT) neuronal firing and release are not necessarily correlated with 5-HT metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Neurobiology of opiate abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

The effect of amperozide on uptake and release of [3H]-dopamine in vitro from perfused rat striatal and limbic brain areas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Drugs and Reinforcement Mechanisms: A Critical Review of the Catecholamine Theory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Inhibition of 5-hydroxytryptamine neuronal activity by the 5-HT agonist, DOI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Morphine-induced activation of A10 dopamine neurons in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Molecular pharmacology and biology of 5-HT1C receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Effects of amperozide on psychostimulant-induced hyperlocomotion and dopamine release in the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

The isomers of cocaine and tropacocaine: effect on 3H-catecholamine uptake by rat brain synaptosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Cellular and molecular mechanisms of drug dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

The 5-HT3 antagonist zacopride attenuates cocaine-induced increases in extracellular dopamine in rat nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Serotonin neurons of the midbrain raphe: ascending projections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Molecular mechanisms of drug addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Organization of ascending serotonin systems in the adult rat brain. A radioautographic study after intraventricular administration of [3h]5-hydroxytryptamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

5-HT3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: A horseradish peroxidase study in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Cocaine and central monoaminergic neurotransmission: a review of electrophysiological studies and comparison to amphetamine and antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area: potential sites for modulation of mesolimbic dopamine neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Action of drugs of abuse on brain reward systems: an update with specific attention to opiates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Effects of a selective 5-HT2 agonist, DOI, on 5-HT neuronal firing in the dorsal raphe nucleus and 5-HT release and metabolism in the frontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

A comparative electrophysiological and biochemical assessment of serotonin (5-HT) and a novel 5-HT agonist (MK-212) on central serotonergic receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

Effects of amperozide in schizophrenia. An open study of a potent 5-HT2 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901267-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(97)01267-5

1 reference

11 February 2018

PubMed ID

9507167

1 reference

11 February 2018